An immunotherapy drug ‘melted’ away tumors in nearly six in 10 colorectal cancer patients without surgery, according to a study presented this weekend at the ASCO conference in Chicago. An immunotherapy drug ‘melted’ away tumors in nearly six in 10 colorectal cancer patients without surgery, according to a study presented this weekend at the ASCO conference in Chicago.